Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs With Angiotensin Type 1 Receptor

doi 10.1021/acs.jcim.7b00424.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Angiotensin Analogs With Divergent Bias Stabilize Distinct Receptor Conformations

Cell
BiochemistryGeneticsMolecular Biology
2019English

The Angiotensin II Type 1 Receptor and Receptor-Associated Proteins

Cell Research
Cell BiologyMolecular Biology
2001English

Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent

Hypertension
Internal Medicine
2010English

Polymorphisms of the Angiotensin II Type 1 Receptor Gene Affect Antihypertensive Response to Angiotensin Receptor Blockers in Hypertensive Chinese

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension

Hypertension
Internal Medicine
1999English

Molecular Characterization of New Selective Peroxisome Proliferator-Activated Receptor Modulators With Angiotensin Receptor Blocking Activity

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy